These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10563528)

  • 1. Activity of serum angiotensin-converting enzyme as a tumour marker of hepatocellular carcinoma.
    Kardum D; Huskic J; Fabijanic D; Banic M; Buljevac M; Kujundzic M; Loncar B
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1209-13. PubMed ID: 10563528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
    Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK
    Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
    Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study.
    Abdel-Razik A; Elhelaly R; Elzehery R; El-Diasty A; Abed S; Elhammady D; Tawfik A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):599-605. PubMed ID: 26741637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
    Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
    Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
    Fabris C; Basso DA; Leandro G; Meggiato T; Elba S; Panozzo MP; Del Favero G; Fogar P; Di Mario F; Naccarato R
    Cancer; 1991 Oct; 68(8):1795-8. PubMed ID: 1717126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
    Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
    World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
    Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Role of Blood Tumor Markers in Predicting Hepatocellular Carcinoma in Liver Cirrhosis Patients Undergoing Liver Transplantation.
    Kim Y; Park YH; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Lee SG
    Ann Transplant; 2016 Oct; 21():660-667. PubMed ID: 27777395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma.
    Song BC; Chung YH; Kim JA; Choi WB; Suh DD; Pyo SI; Shin JW; Lee HC; Lee YS; Suh DJ
    Cancer; 2002 Jan; 94(1):175-80. PubMed ID: 11815974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma.
    Gad A; Tanaka E; Matsumoto A; Wahab MA; Serwah Ael-H; Attia F; Ali K; Hassouba H; el-Deeb Ael-R; Ichijyo T; Umemura T; Muto H; Yoshizawa K; Kiyosawa K
    World J Gastroenterol; 2005 Nov; 11(42):6607-12. PubMed ID: 16425352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis.
    Sarwar S; Khan AA; Tarique S
    J Coll Physicians Surg Pak; 2014 Jan; 24(1):18-22. PubMed ID: 24411536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma.
    Yagmur E; Rizk M; Stanzel S; Hellerbrand C; Lammert F; Trautwein C; Wasmuth HE; Gressner AM
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):755-61. PubMed ID: 17700260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
    Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
    J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
    World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma.
    Soliman HH; Nagy H; Kotb N; Alm El-Din MA
    Int J Biol Markers; 2012 Jul; 27(2):e125-31. PubMed ID: 22388957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of endothelin-1 concentration and angiotensin-converting enzyme activity with the staging of liver fibrosis.
    Kardum D; Fabijanić D; Lukić A; Romić Z; Petrovecki M; Bogdanović Z; Jurić K; Urek-Crncević M; Banić M
    Coll Antropol; 2012 Jun; 36(2):413-8. PubMed ID: 22856224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
    Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
    Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis.
    Iavarone M; Lampertico P; Ronchi G; Del Ninno E; Zanella A; Colombo M
    J Viral Hepat; 2003 Nov; 10(6):423-6. PubMed ID: 14633174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.